Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > A Catalyst New Event

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron Nov 22, 2022 3:59pm

171 Views

Post# 35119789

RE:RE:RE:RE:RE:RE:RE:A Catalyst New Event

@carbonw. I have a sister who likes to wager, especially about politics. She usually bets to back up her political biases. That trial is Terminated.

The GOBLET trial may be World Class. Merck has seen fit to try Keytruda on MM. Some very sophisticated folks involved I mightt add.

What is not to like.

PS. My sister does not wager with me any more. Please do not put ire on my hole. Cheers

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario